What is BioMCN?
BioMCN, established in late 2006 and based in Farmsum, The Netherlands, is a pioneering company in the renewable energy space. It has successfully converted an existing methanol plant to utilize bio-synthesis gas derived from crude glycerin. This process yields second-generation biofuels, which are classified as such by the European Union's Renewable Energy Directive. These advanced biofuels offer substantial reductions in greenhouse gas emissions, do not compete with food production, and help preserve biodiversity while also lowering energy consumption. BioMCN is demonstrating the immediate viability of these advanced, sustainable fuel solutions.
How much funding has BioMCN raised?
BioMCN has raised a total of $45.3M across 1 funding round:
Unspecified
$45.3M
Unspecified (2009): $45.3M with participation from Waterland Private Equity
Key Investors in BioMCN
Waterland Private Equity
Waterland Private Equity is an independent investment firm with substantial financial resources, specializing in supporting entrepreneurs in achieving accelerated growth through organic expansion and acquisitions. Their focus on sustainability aligns with BioMCN's mission.
What's next for BioMCN?
The substantial enterprise-level backing positions BioMCN for significant scaling and market penetration. This strategic investment is likely to fuel further technological development, expansion of production capacity, and broader market adoption of its innovative second-generation biofuels. The company's focus on waste-derived feedstocks aligns with global sustainability trends and regulatory support for cleaner energy alternatives, suggesting a strong growth trajectory ahead.
See full BioMCN company page
